Drug Profile
Tenecteplase biosimilar - Reliance Life Sciences
Alternative Names: R-TPR-012; TenecteRelLatest Information Update: 25 Oct 2021
Price :
$50
*
At a glance
- Originator Reliance Life Sciences
- Class Blood coagulation factors; Plasminogen activator enzymes; Serine endopeptidases; Thrombolytics
- Mechanism of Action Plasminogen activators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Myocardial infarction
Most Recent Events
- 05 Jul 2020 Launched for Myocardial infarction in India (IV) before July 2020 (Reliance Life sciences website, July 2020)
- 04 Jul 2020 Registered for Myocardial infarction in India (IV) before July 2020 (Reliance Life sciences website, July 2020)
- 26 Sep 2016 Preclinical trials in Myocardial infarction in India (IV)